This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Palmitoylethanolamide natural
Endogenous fatty acid amide with analgesic and neuroprotective action.
Endogenous fatty acid amide with analgesic and neuroprotective action. Key active compounds include Palmitoylethanolamide, Endocannabinoid-like compound.
Palmitoylethanolamide, along with Endocannabinoid-like compound, are the primary bioactive compounds in PEA Source. The specific pharmacological pathways require further study, though traditional use supports its efficacy.
Endocannabinoid modulator
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Mast cell stabilizer
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Neuroprotective
Chronic pain
Based on traditional use; clinical evidence limited
Neuropathy
Based on traditional use; clinical evidence limited
Inflammation
Based on traditional use; clinical evidence limited
Sciatic pain
Based on traditional use; clinical evidence limited
Found an error or have a correction for PEA Source?
Report an Issue →